Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
   Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"
   NEUROPSYCHOPHARMACOLOGY
   
   J.J. Clifford et al., "Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"", NEUROPSYCH, 25(4), 2001, pp. 527-536
2. Mayfield, RD; Zahniser, NR
   Dopamine D-2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent
   MOLECULAR PHARMACOLOGY
   
   R.D. Mayfield e N.R. Zahniser, "Dopamine D-2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent", MOLEC PHARM, 59(1), 2001, pp. 113-121
3. Bunny, EB; Appel, SB; Brodie, MS
   Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   E.B. Bunny et al., "Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area", J PHARM EXP, 297(2), 2001, pp. 696-703
4. Wicke, K; Garcia-Ladona, J
   The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   K. Wicke e J. Garcia-Ladona, "The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors", EUR J PHARM, 424(2), 2001, pp. 85-90
5. Diaz, J; Pilon, C; Le Foll, B; Gros, C; Triller, A; Schwartz, JC; Sokoloff, P
   Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons
   JOURNAL OF NEUROSCIENCE
   
   J. Diaz et al., "Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons", J NEUROSC, 20(23), 2000, pp. 8677-8684
6. Wang, YY; Xu, R; Sasaoka, T; Tonegawa, S; Kung, MP; Sankoorikal, EB
   Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions
   JOURNAL OF NEUROSCIENCE
   
   Y.Y. Wang et al., "Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions", J NEUROSC, 20(22), 2000, pp. 8305-8314
7. Millan, MJ; Girardon, S; Monneyron, S; Dekeyne, A
   Discriminative stimulus properties of the dopamine D-3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D-3 versus D-2 receptors
   NEUROPHARMACOLOGY
   
   M.J. Millan et al., "Discriminative stimulus properties of the dopamine D-3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D-3 versus D-2 receptors", NEUROPHARM, 39(4), 2000, pp. 586-598
8. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
   S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1048-1062
9. Boulay, D; Depoortere, R; Perrault, G; Borrelli, E; Sanger, DJ
   Dopamine D-2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D-2/D-3 receptor agonists
   NEUROPHARMACOLOGY
   
   D. Boulay et al., "Dopamine D-2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D-2/D-3 receptor agonists", NEUROPHARM, 38(9), 1999, pp. 1389-1396
10. Jung, MY; Schmauss, C
    Decreased c-fos responses to dopamine D-1 receptor agonist stimulation in mice deficient for D-3 receptors
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M.Y. Jung e C. Schmauss, "Decreased c-fos responses to dopamine D-1 receptor agonist stimulation in mice deficient for D-3 receptors", J BIOL CHEM, 274(41), 1999, pp. 29406-29412
11. QUIRION R; RICHARD J; WILSON A
    MUSCARINIC AND NICOTINIC MODULATION OF CORTICAL ACETYLCHOLINE-RELEASEMONITORED BY IN-VIVO MICRODIALYSIS IN FREELY MOVING ADULT-RATS
    Synapse
    
    R. Quirion et al., "MUSCARINIC AND NICOTINIC MODULATION OF CORTICAL ACETYLCHOLINE-RELEASEMONITORED BY IN-VIVO MICRODIALYSIS IN FREELY MOVING ADULT-RATS", Synapse, 17(2), 1994, pp. 92-100